| Yazarlar (18) |
Mustafa Kemal Celen
Dicle University, Faculty Of Medicine, Türkiye |
|
Kamuran Turker
Bağcilar Eğitim ve Araştirma Hastanesi, Türkiye |
|
Nefise Oztoprak
Antalya Education And Research Hospital, Türkiye |
|
Alper Sener
Çanakkale Onsekiz Mart Üniversitesi, Türkiye |
|
Nazan Tuna
Sakarya Üniversitesi, Türkiye |
|
Nevin Ince
Nevsehir State Hospital, Türkiye |
|
Ilknur Erdem
Tekirdağ Namık Kemal Üniversitesi, Türkiye |
|
Nese Saltoglu
Istanbul University-Cerrahpasa, Türkiye |
|
Davut Ozdemir
Düzce Üniversitesi, Türkiye |
|
Tuba Dal
Dicle University, Faculty Of Medicine, Türkiye |
Prof. Dr. Mustafa Kasım KARAHOCAGİL
Van Yüzüncü Yıl Üniversitesi, Türkiye |
|
Fatma Sirmatel
Bolu Abant İzzet Baysal Üniversitesi, Türkiye |
|
Fusun Zeynep Akcam
Isparta University Of Applied Sciences, Türkiye |
|
Fatma Eksi Polat
Bağcilar Eğitim ve Araştirma Hastanesi, Türkiye |
|
Mehmet Cabalak
T. C. Sağlık Bakanlığı, Bingol Devlet Hastanesi, Türkiye |
|
Suzan Sacar
Çanakkale Onsekiz Mart Üniversitesi, Türkiye |
|
Selma Tosun
Manisa State Hospital, Türkiye |
|
Fehmi Tabak
Istanbul University-Cerrahpasa, Türkiye |
| Özet |
| Chronic hepatitis B is a major public health problem in our country. Hepatitis A vaccination in HBV carriers who did not encounter with Hepatitis A virus is also significant. We aimed to evaluate the rate of exposure to HAV in HBsAg-positive persons, and the distribution of seronegative individuals according to age groups. Medical records of 4793 patients from 14 centers who were positive for hepatitis B surface antigen (HBsAg). A total 3514 cases (73.3%) were male and 1279 (26.7) were female. The HBsAg positive patients who were previously tested for HAV IgG at the time of firstly admitted to a center. HBsAg positive patients who were previously not tested for HAV IgG were tested and these . patients were confirmed serologically for HAV. The distribution of cases according to age were determined. In this study, 4793 HBsAg-positive patients were evaluated. The ratio of testing of anti-HAV IgG was very low during the first visit (54.2%). Seronegativity was highest in the age group under 19 years of age (26.2%) followed by 20-25 age group (15.5%) and 26-29 age group (12.5%). Testing of HAV serology should not be ignored in especially HBsAg-positive young adults and seronegative young adults should be vaccinated. |
| Anahtar Kelimeler |
| Anti-HAV IgG | HBsAg | Hepatitis A |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | SCOPUS dergilerinde yayınlanan tam makale |
| Dergi Adı | Journal of Pure and Applied Microbiology |
| Dergi ISSN | 0973-7510 Wos Dergi Scopus Dergi |
| Makale Dili | İngilizce |
| Basım Tarihi | 08-2014 |
| Cilt No | 8 |
| Sayı | 4 |
| Sayfalar | 3063 / 3068 |
